Title of article
Risk assessment for carnitine
Author/Authors
Hathcock، نويسنده , , John N. and Shao، نويسنده , , Andrew، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2006
Pages
6
From page
23
To page
28
Abstract
Carnitine is a conditionally essential amino acid-like compound involved in the transport of long-chain fatty acids into the mitochondria during the β-oxidation process. Carnitine has become an increasingly popular ingredient in dietary supplements, especially weight loss and some sports nutrition products. A number of clinical trials have been conducted examining the effect of carnitine supplementation on weight loss and energy balance. Regarding safety, systematic evaluation of the research designs and data do not provide a basis for risk assessment and the usual safe upper level of intake (UL) derived from it unless the newer methods described as the observed safe level (OSL) or highest observed intake (HOI) are utilized. The OSL risk assessment method indicates that the evidence of safety is strong at intakes up to 2000 mg/day l-carnitine equivalents for chronic supplementation, and this level is identified as the OSL. Although much higher levels have been tested without adverse effects and may be safe, the data for intakes above 2000 mg/day are not sufficient for a confident conclusion of long-term safety.
Keywords
Upper Level of Intake (UL) , carnitine , Observed Safe Level (OSL)
Journal title
Regulatory Toxicology and Pharmacology
Serial Year
2006
Journal title
Regulatory Toxicology and Pharmacology
Record number
1487876
Link To Document